Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-05-08 | Dr. William G. Rice, Ph.D., Chairman, President and Chief Executive Officer of the Corporation is not an independent director because of his role in the Corporation’s management team. |
| 2020-04-24 | Dr. Rice, age 61, joined Aptose as Chairman and Chief Executive Officer in October 2013... Dr. Rice makes valuable contributions to the Board based on his Ph.D. in Biochemistry, and his over 25 years of experience in the biotechnology industry... Executive directors are not entitled to directors’ compensation... The following table details the compensation information for the fiscal years ended December 31, 2018 and December 31, 2019 of the Corporation for the Named Executive Officers... Dr. William G. Rice Chairman, President and Chief Executive Officer 2019 Salary 561,854, Option awards 516,298, Non-equity incentive plan compensation 407,344, All other compensation 26,400, Total compensation 1,511,896. |
| 2021-04-21 | Dr. Rice, age 62, joined Aptose as Chairman and Chief Executive Officer in October 2013... Dr. Rice makes valuable contributions to the Board based on his Ph.D. in Biochemistry, and his over 25 years of experience in the biotechnology industry as a senior executive and as a corporate director. |
| 2022-04-20 | Dr. Rice, age 63, joined Aptose as Chairman and Chief Executive Officer in October 2013... Dr. Rice makes valuable contributions to the Board based on his Ph.D. in Biochemistry, and his over 25 years of experience in the biotechnology industry as a senior executive and as a corporate director. Compensation Table shows total compensation of $1,871,825 for 2021. |
| 2023-04-19 | Dr. Rice receives no remuneration for his service as Chairman of the Board and director. |
| 2024-05-15 | Dr. Rice, age 65, serves as the President, Chief Executive Officer, Chairman of the Board, and member of the Research and Development Committee ("R&D Committee") of Aptose... Dr. Rice receives no remuneration for his service as Chairman of the Board and director or as a member of the R&D Committee of the Board. |
Data sourced from SEC filings. Last updated: 2026-02-03